Home Sectors Healthcare Present Fundamentals: MiMedx Group Inc (NASDAQ: MDXG)

Present Fundamentals: MiMedx Group Inc (NASDAQ: MDXG)


MiMedx Group Inc trades as part of the healthcare sector and is part of the medical devices industry. The company CEO is David Coles. MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.

Previous Intraday Trading Performance:

The MDXG stock showed a previous change of -19.40% with an open at 3.90 and a close of 2.95. It reached an intraday high of 4.75 and a low of 3.66.

SeekingAlpha:  MasTec +5.2% on move to MidCap 400; FTK -4.1% on exiting SmallCap 600


The stock has a market cap of $327.6m with 111.0m shares outstanding, of which the float is 97.5m shares. Trading volume reached 28,026,250 shares compared to its average volume of 2,758,730 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, MiMedx Group Inc shares returned -53.91% and in the past 30 trading days it returned -52.27%. Over three months, it changed -33.71%. In one year it has changed -76.27% and within that year its 52-week high was 18.25 and its 52-week low was 3.01. MDXG stock is -1.83% above its 52 Week Low.

Our calculations show a 200 day moving average of 6.96 and a 50 day moving average of 5.54. Currently MDXG stock is trading -57.63% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

PR Newswire:  Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600


The last annual fiscal EPS for the company was reported at 0.11 that ended on 31st of December 2016, which according to the previous close, that is a PE of 26.82.The TTM EPS is 0.05, which comes to a TTM PE of 59.00.

Below was the last reported quarterly diluted earnings per share:

3rdQtr of 2017 (Reported on 10/26/2017): 0.15
2ndQtr of 2017 (Reported on 07/26/2017): 0.07
1stQtr of 2017 (Reported on 04/28/2017): 0.04
4thQtr of 2016 (Reported on 02/23/2017): 0.05
3rdQtr of 2016 (Reported on 10/27/2016): 0.03

Indicators to Watch:

Based on the latest filings, there is 50.30% of institutional ownership.

The current calculated beta is 1.22.

SeekingAlpha:  Tech and consumer goods stock down in premarket trade

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 26.05%, return on assets is 19.18% and price-to-book is 4.85.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 0  :Past Performance Score
 4  :Financial Strength Score
 0  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.